Published by Global Banking & Finance Review®
Posted on March 2, 2026
2 min readLast updated: April 2, 2026
Add as preferred source on Google
British medtech firm Smith & Nephew reported a 15.5% surge in annual trading profit to $1.21 billion for the year ended December 31, 2025, driven by its ongoing turnaround plan delivering cost savings and broad-based growth across its divisions.
By Yamini Kalia
March 2 (Reuters) - Smith & Nephew's CEO backed the company's 2026 guidance on Monday despite potential disruptions from the Middle East conflict and higher tariff costs, after the medical products maker broadly met targets for profit and revenue last year.
Smith & Nephew, which makes orthopaedic implants, wound dressings, and other surgical aids, finished a three‑year turnaround that revamped its orthopaedic division, cut costs, and lifted growth in other units, after inflation and supply‑chain disruptions hit margins.
The company, which expects another $60 million tariff hit in 2026 after a $17 million charge last year, also has meaningful Middle East operations, where the war in Iran has added to uncertainty.
"We've got our business continuity and crisis teams deployed to ensure the safety and well-being of our employees and ensuring the continuity of our business there," CEO Deepak Nath told Reuters.
Smith & Nephew has a presence in Dubai and Riyadh with operations throughout the Middle East via distributors.
Nath added that the main risk of the conflict would be a Suez Canal closure, which could lengthen shipping times for products moving from China to Europe, but added that current inventory levels support its demand in the Middle East for now.
"At this stage, given what we know today, we stand behind the guidance that we've communicated," Nath said.
SHARES DROP 5% AFTER RESULTS
Some analysts disagreed.
"We do not see today's results as sufficient to underpin 2026 guidance at this stage," Jack Reynolds-Clark, a RBC Capital Markets analyst said, adding that there remains significant risk of guidance downgrades over the year.
Shares in the company dropped more than 5% on Monday, underperforming a 1% fall on the wider London market.
The company forecast a trading profit of about $1.3 billion for 2026 and reiterated its expectation of roughly 6% underlying revenue growth.
It reported a trading profit of $1.21 billion for 2025, up 15.5% and in line with market expectations.
(Reporting by Yamini Kalia in Bengaluru; Editing by Rashmi Aich and Toby Chopra)
Smith & Nephew reported a trading profit of $1.21 billion for the year ended December 2025.
The company's annual profit increased by 15.5%, rising from $1.05 billion last year to $1.21 billion in 2025.
The profit growth was driven by successful turnaround plans, cost savings, and boosted growth across the company's divisions.
The financial results were reported by Yamini Kalia in Bengaluru and edited by Rashmi Aich.
Explore more articles in the Finance category
